PeptideDB

Peptide YY (3-36) (human)

CAS No.: 123583-37-9

Peptide YY (3-36) (human) also called PYY (3-36) (human), is a Y2 receptor agonist, it is released from the body’s gast
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 123583-37-9
Sequence H-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2
Sequence Single IKPEAPGEDASPEELNRYYASLRHYLNLVTRQRY-NH2
Molecular Formula C180H279N53O54
Molecular Weight 4049.52
Synonyms PYY (3-36) (human)
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Application Gastrointestinal Research|Obesity Research
Description Peptide YY (3-36) (human) also called PYY (3-36) (human), is a Y2 receptor agonist, it is released from the body’s gastrointestinal tract in proportion to caloric intake. It has been shown that peripheral injection of PYY (3-36) in rats inhibited food intake and reduced weight gain. In addition, infusion of PYY (3-36) in humans significantly decreased appetite and reduced food intake by 33% over 24h, which suggests that PYY (3-36) has a role in ‘longer term’ regulation of food intake. Thus, the PYY (3-36) may represent a lead compound for the development of drugs for the treatment of obesity.
References 1.  Rapid alterations in the plasma membrane structure of macrophages stimulated with bacterial lipopeptides. B.Uhl et al., Eur. J. Cell Biol., 58, 90 (1992) 2.  Peptide YY(3-36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: implications for hypothalamic regulation of energy homeostasis. C.Acuna-Goycolea and A.N.van den Pol, J. Neurosci., 25, 10510 (2005) 3.  Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions. G.H.Ballantyne, Obes. Surg., 16, 651 (2006) 4.  Reversible PEGylation of peptide YY3-36 prolongs its inhibition of food intake in mice. Y.Shechter et al., FEBS Lett., 579, 2439 (2005) 5.  Inhibition of food intake in obese subjects by peptide YY3-36. R.L.Batterham et al., N. Engl. J. Med., 349, 941 (2003) 6.  Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. I.G.Halatchev and R.D.Cone, Cell Metab., 1, 159 (2005) 7.  A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). G.A.Eberlein et al., Peptides, 10, 797 (1989) 8.  Gut hormone PYY(3-36) physiologically inhibits food intake. R.L.Batterham et al., Nature, 418, 650 (2002) 9.  NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice. Moriya R, et al. Peptides. 2010;31(4):671-675.